UNITED STATES — September 10, 2026 —
New dual-method testing protocol brings third-party HPLC and mass-spectrometry purity verification and batch-matched COAs to every research compound Life Link Research offers in 2026.
Life Link Research, a US-based research peptide supplier, today announced it has adopted HPLC and mass-spectrometry (MS) verification across its full research catalog, with batch-matched Certificates of Analysis (COAs) now available for every compound. The upgrade establishes dual-method purity testing as the company’s catalog-wide standard for research-use-only peptides.
Every compound is now measured for purity by high-performance liquid chromatography and confirmed for identity by mass spectrometry before release, and each batch is documented with its own certificate tied to that production lot. The standard applies to the entire catalog with no product excluded and no exceptions by category or price tier.
What Life Link Research Announced: Catalog-Wide HPLC + Mass-Spec Testing
The change is specific. Every research compound in the Life Link Research catalog now passes through two independent analytical methods before it reaches researchers.
HPLC measures purity as a percentage and flags impurities or truncated sequences.
Mass spectrometry confirms the compound’s identity by verifying its molecular weight.
A batch-specific COA is then issued for that production lot.
The protocol is effective across the 2026 catalog and covers every category the company stocks, from repair and recovery compounds such as BPC-157 and TB-500 to metabolic and longevity research compounds including GHK-Cu and NAD+. There are no exclusions and no tiers.
Testing is performed through Janoshik Analytical and US-based laboratories, and the resulting certificate is matched to the exact batch a researcher receives. Where a compound’s earlier process relied on a single method or a product-level document, the new protocol applies both analytical methods to every lot and issues a fresh certificate for each one.
Two Methods, One Standard: HPLC purity + mass-spec identity feed a batch-matched COA.
Why HPLC and Mass Spectrometry Matter for Research Peptide Purity
For research peptides, a single test cannot answer both questions that matter. HPLC answers how pure a sample is. Mass spectrometry answers whether the sample is the correct molecule. A supplier needs both, because each method covers the other’s blind spot.
High-performance liquid chromatography separates the components of a sample and reports purity as the percentage that the main peak area contributes to the total peak area. That measurement catches impurities, degradation products, and truncated sequences left over from synthesis. What HPLC cannot do on its own is prove the main peak is the intended compound.
Mass spectrometry closes that gap. By measuring molecular weight, it confirms identity, and it does so independently of the chromatography result. The two methods together are the research-grade standard because either one alone leaves a real hole.
Peer-reviewed analytical work illustrates the point clearly: linear and cyclic forms of the same peptide can share identical masses, so mass spectrometry alone cannot always tell them apart, while HPLC separation can, according to a 2024 study published in the journal Molecules. Purity confirmation and identity confirmation are two different jobs, and dual-method testing is how a supplier does both.
Batch-Matched COAs and Full Transparency for Every Order
Under the new standard, each batch comes its own linked to that production lot. The certificate reports the HPLC purity percentage, the mass-spectrometry identity confirmation, and, where applicable, sterility and endotoxin results. The batch number on the document matches the batch number on the vial a researcher receives.
That distinction is the point. A certificate from an earlier production run remains a record of a different batch, so Life Link Research issues documentation for each individual lot as it is produced. Researchers can obtain the COA that corresponds to their order, which lets a lab confirm identity and purity against the specific material in hand before any research use.
The result is a documentation trail that a research team can verify independently, order by order, and reference directly in its own records. For a laboratory that logs the provenance of every input, a batch-level certificate turns sourcing from an assumption into a documented fact.
A Direct Response to Batch-Consistency Concerns in the Peptide Market
Batch-to-batch consistency is the research-peptide sector’s most persistent quality concern, and it is the issue this protocol is built to answer. Independent testing has shown that peptide products sold by online sellers without a prescription can fall far short of their labels.
One peer-reviewed market-surveillance study measured semaglutide purity between 7.7 and 14.37 percent in vials labeled as 99 percent, meaning a researcher may be working with a large fraction of unknown material, according to aThe same guidance identifies the core red flag as a supplier who cannot provide a batch-specific COA backed by a named, contactable third-party lab.
-wide dual-method testing with per-batch certificates answers that concern directly. Purity is measured on every lot, identity is confirmed on every lot, and the paperwork is traceable to a named laboratory. By documenting each batch as it is produced, Life Link Research aims to make consistency a matter of record for the research community that depends on it. A supplier that publishes a batch-matched certificate for every compound gives a research team the one thing crowd-sourced COA sharing exists to find, delivered as a standard part of the order.
“Researchers depend on knowing exactly what is in every vial, and that confidence has to come from data, not from a label,” said Michael Turner, Product Manager at Life Link Research. “We adopted dual-method testing across the entire catalog because purity and identity are two separate questions, and a research team deserves a documented answer to both for the specific batch they receive. Publishing a batch-matched certificate for every compound is how we hold ourselves to that standard, and it is the standard we believe the field should expect from any serious supplier.”
What Catalog-Wide Verification Means for Researchers
For the research community, the practical value of the new standard is reproducibility. When identity and purity are documented for the exact batch in use, a laboratory can account for the material in its protocols and compare results across studies with greater confidence. Verified identity removes a common source of uncertainty at the very start of an experiment.
The standard is intended strictly for laboratory and research use. It does not speak to human health, performance, or any therapeutic application, and Life Link Research makes no such claims. What catalog-wide verification offers is narrower and more useful for its audience: reduced sourcing risk, clearer documentation, and a consistent evidentiary basis for research work. For labs that build reproducibility on well-characterized inputs, a batch-matched COA on every compound is a meaningful reduction in one of research sourcing’s larger variables.
“Our goal is to help raise the documentation standard across the research peptide field,” said Sarah Coleman, Laboratory Assistant at Life Link Research. “Dual-method testing on every batch is the foundation, and our roadmap extends it with continued third-party verification and broader public access to certificates over time.”
How to Read a Research Peptide COA (and What to Verify)
A is only as useful as a researcher’s ability to read it. Five checks confirm a document supports the material in hand:
Purity percentage. Confirm the HPLC purity figure and that it reflects main-peak area against total peak area.
Identity via mass. Verify that mass spectrometry confirms the molecular weight of the intended compound.
Batch number match. Check that the batch or lot number on the certificate matches the number printed on your vial.
Lab attribution. Confirm the testing laboratory is named and contactable, with a verifiable identity behind the result.
Test date. Verify the certificate corresponds to a recent, relevant production run.
A certificate that clears all five points is traceable to the specific batch a researcher is using. A document that fails any one of them, especially a batch-number mismatch, is a record of different material. Reading the COA carefully is the single most direct way a lab can verify a research peptide supplier’s claims before use.
About Life Link Research
is a US-based research peptide supplier serving laboratory and research customers. The company offers a broad catalog of research compounds and blends across repair, metabolic, growth-factor, and longevity research categories, all sold strictly for research use only. Its catalog-wide testing standard combines reverse-phase HPLC purity analysis and mass-spectrometry identity confirmation through Janoshik Analytical and US-based laboratories, with batch-matched Certificates of Analysis available for every compound.
Life Link Research is committed to documentation and transparency as the basis for research-grade sourcing. More information is available at
Disclaimer
All Life Link Research products are sold for research use only. They are not for human or animal consumption, are not FDA-approved, and have not been evaluated for safety or efficacy in humans. Nothing in this release constitutes medical advice or a health, dosing, or performance claim. Statements regarding future testing plans and roadmap are forward-looking and subject to change. Products are intended for qualified researchers aged 18 or older.
Media ContactCompany Name: Life Link ResearchContact Person: Media RelationsEmail: Send EmailCountry: United StatesWebsite: https://lifelinkresearch.com/
